Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens

Monocyte-derived Dendritic cells (DCs) have successfully been employed to induce immune responses against tumor-associated antigens in patients with various cancer entities. However, objective clinical responses have only been achieved in a minority of patients. Additionally, generation of GMP-compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hänel, Gerulf, Angerer, Caroline, Petry, Katja, Lichtenegger, Felix S., Subklewe, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614222/
https://www.ncbi.nlm.nih.gov/pubmed/34821951
http://dx.doi.org/10.1007/s00262-021-03109-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614222/
https://www.ncbi.nlm.nih.gov/pubmed/34821951
http://dx.doi.org/10.1007/s00262-021-03109-w

Ejemplares similares